中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2013年
5期
785-790
,共6页
韩永%郭晖%蔡明%许晓光%黄海燕%徐燕杰%王强%冯凯%石炳毅
韓永%郭暉%蔡明%許曉光%黃海燕%徐燕傑%王彊%馮凱%石炳毅
한영%곽휘%채명%허효광%황해연%서연걸%왕강%풍개%석병의
器官移植%肾移植%移植肾穿刺%活组织检查,针吸%病理活检%诊断%治疗%其他基金%器官移植图片文章
器官移植%腎移植%移植腎穿刺%活組織檢查,針吸%病理活檢%診斷%治療%其他基金%器官移植圖片文章
기관이식%신이식%이식신천자%활조직검사,침흡%병리활검%진단%치료%기타기금%기관이식도편문장
organ transplantation%renal transplantation%transplant renal biopsy%biopsy%needle aspiration%pathological biopsy%diagnosis%treatment%other grants-supported paper%photographs-containing paper of organ transplantation
背景:移植肾活检病理学组织学早期诊断意义重大,单中心回顾性研究临床诊断与治疗较少.目的:通过对肾功能不全移植肾进行常规穿刺病理活检,根据病理诊断采取相应临床治疗方式,观察治疗效果,同时明确移植肾穿刺病理活检的安全性以及在临床诊治中的意义及其重要性.方法:选取解放军第309医院器官移植中心202例肾移植患者为研究对象,其中80例为肾移植后移植肾功能延迟恢复,122例肌酐不明原因升高.在 B 超引导下应用活检穿刺针行移植肾穿刺活检,对活检组织标本予以相应染色和病理组织学观察,并进行相应的临床治疗.结果与结论:穿刺组织中,除3例(1.5%)由于组织少难以诊断,其余病理诊断移植肾正常12例(5.9%),缺血再灌注损伤合并(或)急性肾小管坏死28例(13.9%),轻度钙调磷酸酶抑制剂类免疫抑制剂急性毒性损伤22例(10.9%),轻度钙调磷酸酶抑制剂类免疫抑制剂慢性毒性损伤12例(5.9%),超急性排斥反应1例(0.5%),疑为急性排斥反应29例(14.4%),急性 T 细胞性排斥反应34例(16.8%),急性抗体介导性排斥反应19例(9.4%),慢性 T 细胞介导排斥反应16例(7.9%),慢性 T 细胞介导排斥反应伴急性 T 细胞介导性排斥反应12例(5.9%),慢性抗体介导性排斥反应3例(1.5%),高血压因素4例(2.0%),间质纤维化和肾小管萎缩,未发现特定致病因素所致病变2例(1.0%),缺血性坏死2例(1.0%),移植后肾病复发3例(1.5%),C4d 免疫组化染色阳性23例(11.4%),未发现患者及移植肾的不良反应.
揹景:移植腎活檢病理學組織學早期診斷意義重大,單中心迴顧性研究臨床診斷與治療較少.目的:通過對腎功能不全移植腎進行常規穿刺病理活檢,根據病理診斷採取相應臨床治療方式,觀察治療效果,同時明確移植腎穿刺病理活檢的安全性以及在臨床診治中的意義及其重要性.方法:選取解放軍第309醫院器官移植中心202例腎移植患者為研究對象,其中80例為腎移植後移植腎功能延遲恢複,122例肌酐不明原因升高.在 B 超引導下應用活檢穿刺針行移植腎穿刺活檢,對活檢組織標本予以相應染色和病理組織學觀察,併進行相應的臨床治療.結果與結論:穿刺組織中,除3例(1.5%)由于組織少難以診斷,其餘病理診斷移植腎正常12例(5.9%),缺血再灌註損傷閤併(或)急性腎小管壞死28例(13.9%),輕度鈣調燐痠酶抑製劑類免疫抑製劑急性毒性損傷22例(10.9%),輕度鈣調燐痠酶抑製劑類免疫抑製劑慢性毒性損傷12例(5.9%),超急性排斥反應1例(0.5%),疑為急性排斥反應29例(14.4%),急性 T 細胞性排斥反應34例(16.8%),急性抗體介導性排斥反應19例(9.4%),慢性 T 細胞介導排斥反應16例(7.9%),慢性 T 細胞介導排斥反應伴急性 T 細胞介導性排斥反應12例(5.9%),慢性抗體介導性排斥反應3例(1.5%),高血壓因素4例(2.0%),間質纖維化和腎小管萎縮,未髮現特定緻病因素所緻病變2例(1.0%),缺血性壞死2例(1.0%),移植後腎病複髮3例(1.5%),C4d 免疫組化染色暘性23例(11.4%),未髮現患者及移植腎的不良反應.
배경:이식신활검병이학조직학조기진단의의중대,단중심회고성연구림상진단여치료교소.목적:통과대신공능불전이식신진행상규천자병리활검,근거병리진단채취상응림상치료방식,관찰치료효과,동시명학이식신천자병리활검적안전성이급재림상진치중적의의급기중요성.방법:선취해방군제309의원기관이식중심202례신이식환자위연구대상,기중80례위신이식후이식신공능연지회복,122례기항불명원인승고.재 B 초인도하응용활검천자침행이식신천자활검,대활검조직표본여이상응염색화병리조직학관찰,병진행상응적림상치료.결과여결론:천자조직중,제3례(1.5%)유우조직소난이진단,기여병리진단이식신정상12례(5.9%),결혈재관주손상합병(혹)급성신소관배사28례(13.9%),경도개조린산매억제제류면역억제제급성독성손상22례(10.9%),경도개조린산매억제제류면역억제제만성독성손상12례(5.9%),초급성배척반응1례(0.5%),의위급성배척반응29례(14.4%),급성 T 세포성배척반응34례(16.8%),급성항체개도성배척반응19례(9.4%),만성 T 세포개도배척반응16례(7.9%),만성 T 세포개도배척반응반급성 T 세포개도성배척반응12례(5.9%),만성항체개도성배척반응3례(1.5%),고혈압인소4례(2.0%),간질섬유화화신소관위축,미발현특정치병인소소치병변2례(1.0%),결혈성배사2례(1.0%),이식후신병복발3례(1.5%),C4d 면역조화염색양성23례(11.4%),미발현환자급이식신적불량반응.
@@@@BACKGROUND: The kidney al ograft biopsy has great pathological and histological significance in the early diagnosis. However, the retrospective study of clinical diagnosis and treatment is rare. OBJECTIVE: To observe the effect of clinical treatments selected according to the pathological diagnosis which obtained through the wel ness puncture biopsy on insufficiency renal al ograft, and to identify the security and significance of grafted renal puncture biopsy in the clinical treatment. METHODS: 202 patients with renal transplantation were selected from the Organ Transplant Center, the 309th Hospital of Chinese PLA. Among them, 80 patients with delayed recovery of kidney function after kidney transplantation and 122 patients were found increasing creatinine content without explanation. With the guidance of B-ultrasound, a puncture needle was used to perform the kidney al ograft biopsy, and the biopsy specimens were stained and histopathological y by observed for the corresponding clinical treatment. RESULTS AND CONCLUSION: Al the patients were wel accepted by biopsy, except three patients (1.5%) were difficult to be diagnosed because of less tissue. Twelve patients (5.9%) had normal graft kidney, 28 patients (13.9%) suffered from ischemia/reperfusion injury combined with acute tubular necrosis, 22 patients (10.9%) appeared with mild acute toxic injury caused by calcium calcineurin inhibitor immunosuppressive drugs, 12 patients (5.9%) had mild chronic toxic injury caused by calcium calcineurin inhibitor immunosuppressive drugs, one patient (0.5%) appeared with hyperacute rejection, 29 patients (14.4%) were doubted with acute rejection, 34 patients (16.8%) suffered with acute T-cel rejection, 10 patients (9.4%) appeared with acute antibody-mediated rejection, 16 patients (7.9%) appeared with chronic T cel -mediated rejection, 12 patients (5.9%) suffered from chronic T cel -mediated rejection combined with acute T cel -mediated rejection, three patients (1.5%) displayed chronic antibody-mediated rejection, four patients (2.0%) showed hypertension and related factors, two patients (1.0%) suffered from interstitial fibrosis and tubular atrophy without specific risk factors caused lesions, two patients (1.0%) presented with ischemic necrosis, three patients (1.5%) presented with nephropathy recurrence after transplantation and 23 patients were positive for C4d immunohistochemical staining. No adverse reaction was found in the patients or in the graft kidney.